Furthermore, in a prostate cancer cell model, the release of TGF-β1-associated EVs triggers fibroblast differentiation into a myofibroblast phenotype supporting angiogenesis in vitro and accelerating tumor growth in vivo [34]. The gene discussed is TGFB1; the disease is neoplasm.